$6.21
0.366.15%
At close: -
$6.14
-0.07-1.13%
After Hours: Apr 25, 6:06 PM EDT
Comments
Loading...
Exagen Stock Guidance | NASDAQ:XGN | Benzinga
Exagen issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/11/2025 | XGN | Exagen | Q1 | 2025 | — | — | — | $14.50M | — | $14.92M | Get Alert |
| 01/12/2025 | XGN | Exagen | Q4 | 2024 | — | — | — | $13.30M | $13.80M | $13.68M | Get Alert |
| 01/12/2025 | XGN | Exagen | FY | 2024 | — | — | — | $55.30M | $55.80M | $55.56M | Get Alert |
| 11/12/2024 | XGN | Exagen | FY | 2024 | — | — | — | $55.00M | $56.00M | $57.22M | Get Alert |
| 08/05/2024 | XGN | Exagen | FY | 2024 | — | — | — | $57.00M | — | $55.75M | Get Alert |
| 05/13/2024 | XGN | Exagen | FY | 2024 | — | — | — | $55.00M | — | $54.16M | Get Alert |
| 03/18/2024 | XGN | Exagen | Q1 | 2024 | — | — | — | $13.00M | $13.50M | $11.49M | Get Alert |
| 03/18/2024 | XGN | Exagen | FY | 2024 | — | — | — | $54.00M | $54.00M | $54.13M | Get Alert |
| 01/07/2024 | XGN | Exagen | FY | 2023 | — | — | — | $50.00M | — | $50.43M | Get Alert |
| 11/13/2023 | XGN | Exagen | FY | 2023 | — | — | — | $50.00M | — | $46.76M | Get Alert |
| 08/07/2023 | XGN | Exagen | Q3 | 2023 | — | — | — | $10.00M | $10.50M | $11.76M | Get Alert |
| 03/20/2023 | XGN | Exagen | Q1 | 2023 | — | — | — | $9.20M | $9.70M | $9.33M | Get Alert |
| 11/14/2022 | XGN | Exagen | FY | 2022 | — | — | — | $40.00M | $43.00M | $38.10M | Get Alert |
| 08/04/2022 | XGN | Exagen | FY | 2022 | — | — | — | $35.00M | $40.00M | $53.35M | Get Alert |
| 05/11/2022 | XGN | Exagen | FY | 2022 | — | — | — | $53.00M | $55.00M | $51.85M | Get Alert |
| 03/22/2022 | XGN | Exagen | FY | 2022 | — | — | — | $51.00M | $53.00M | $56.16M | Get Alert |
| 11/10/2021 | XGN | Exagen | FY | 2021 | — | — | — | $47.00M | $49.00M | $47.97M | Get Alert |
| 08/09/2021 | XGN | Exagen | FY | 2021 | — | — | — | $47.00M | $49.00M | $48.03M | Get Alert |
| 05/11/2021 | XGN | Exagen | FY | 2021 | — | — | — | $47.00M | $49.00M | $47.99M | Get Alert |
| 03/16/2021 | XGN | Exagen | FY | 2021 | — | — | — | $47.00M | $49.00M | $52.64M | Get Alert |
FAQ
What is the most recent guidance for Exagen (XGN)?
There have been no specific sales or earnings guidance reported for Exagen in recent months.
Browse guidance and forecast on all stocks.
